The DOI matches its Crossref record.
Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney
Open accessAbstract
It has been described recently that the nonpeptide AVE 0991 (AVE) mimics the effects of angiotensin-(1–7) [Ang-(1–7)] in bovine endothelial cells. In this study, we tested the possibility that AVE is an agonist of the Ang-(1–7) receptor Mas, in vitro and in vivo. In water-loaded C57BL/6 mice, AVE (0.58 nmol/g body weight) produced a significant reduction in urinary volume (0.06±0.03 mL/60 min [n=9] versus 0.27±0.05 [n=9]; P <0.01), associated with an increase in urinary osmolality. The Ang-(1–7) antagonist A-779 completely blocked the antidiuretic effect of AVE. As observed previously for Ang-(1–7), the antidiuretic effect of AVE after water load was blunted in Mas -knockout mice (0.37±0.10 mL/60 min [n=9] versus 0.27±0.03 mL/60 min [n=11] AVE-treated mice). In vitro receptor autoradiography in C57BL/6 mice showed that the specific binding of 125 I-Ang-(1–7) to mouse kidney slices was displaced by AVE, whereas no effects were observed in the binding of 125 I-angiotensin II or 125 I-angiotensin IV. Furthermore, AVE displaced the binding of 125 I-Ang-(1–7) in Mas -transfected monkey kidney cells (COS) cells (IC 50 =4.75×10 −8 mol/L) and of rhodamine–Ang-(1–7) in Mas -transfected Chinese hamster ovary (CHO) cells. It also produced NO release in Mas -transfected CHO cells blocked by A-779 but not by angiotensin II type-1 (AT 1 ) and AT 2 antagonists. Contrasting with these data, the antidiuretic effect of AVE was totally blocked by AT 2 antagonists and partially blocked (≈60%) by AT 1 antagonists. The binding data, the results obtained in Mas -knockout mice and in Mas -transfected cells, show that AVE is a Mas receptor agonist. Our data also suggest the involvement of AT 2 /AT 1 -related mechanisms, including functional antagonism, oligomerization or cross-talk, in the renal responses to AVE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Self-citationACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis
Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12159 · Cited by 542
Li, X. C., Zhang, J., & Zhuo, J. L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.005 · Cited by 435
ACE2, Much More Than Just a Receptor for SARS-COV-2
Samavati, L., & Uhal, B. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00317 · Cited by 364
Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 339
Metadata
- Authors
- Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., Bleich, M., & Santos, R. A. S.
- Venue
- Hypertension
- Published
- 2004-10
- Volume
- 44
- Issue
- 4
- Pages
- 490-496
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2137225581
- Cited by
- 175
- References
- 0
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney. https://app.cochat.ai/papers/10.1161/01.hyp.0000141438.64887.42
- The paper
- Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., Bleich, M., & Santos, R. A. S. (2004). Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney. Hypertension. https://doi.org/10.1161/01.hyp.0000141438.64887.42
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.